Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis.
Janine Astrid van TilCatharina G M Groothuis-OudshoornMarieke Gm WeerninkClemens von BirgelenPublished in: The patient (2021)
This study demonstrated significant preference heterogeneity among patients with atrial fibrillation and linked these preferences to differences in background characteristics. Country of residence and currently prescribed therapy influenced patient preferences in both the MLA and LCA models.